Skip to Main Content

The U.S. Defense Department has awarded $3.5 million to a Cambridge, Mass., biotech that says it has figured out a way to make blood platelets from stem cells, a technology the military believes could be useful in treating battlefield and civilian casualties.

Platelet BioGenesis, which was founded in 2014, said Wednesday that the grant will help the startup develop a bioreactor that is key to the production of platelets, a critical component of blood that promotes clotting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • I,m glad to read such a detailed description of your work. I,m sure you will make a great contribution to medical science.

Comments are closed.